XNYS
ALBpA
Market cap12bUSD
Oct 08, Last price
44.26USD
1D
-0.72%
1Q
-15.73%
Name
Albemarle Corp
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Albemarle Corporation is a global enterprise dedicated to the creation, production, and distribution of advanced specialty chemicals. The company's operations are divided into three principal divisions: Lithium, Bromine, and Catalysts. The Lithium segment manufactures and supplies a variety of lithium-based compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and other specialized lithium products. It also provides essential reagents such as butyllithium and lithium aluminum hydride. These materials are vital for numerous applications, such as the production of lithium batteries for consumer electronics and electric vehicles, high-performance lubricating greases, thermoplastic elastomers used in items like car tires, shoe soles, and plastic bottles, and as catalysts in various chemical reactions. Their utility further extends to organic synthesis processes within steroid chemistry, vitamin production, life sciences, and the pharmaceutical industry. Beyond lithium, this segment also offers cesium compounds for chemical and pharmaceutical sectors, along with zirconium, barium, and titanium components specifically for pyrotechnical uses, including airbag initiators. Completing its service offerings, it provides technical guidance for handling reactive lithium products and recycling services for lithium-containing by-products. The Bromine segment focuses on elemental bromine and an array of bromine-derived fire safety innovations. Its product range includes distinct specialty chemicals like elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other fine bromine chemicals. These are applied in chemical synthesis, drilling and completion fluids for the oil and gas industry, mercury emission control, water purification, and the processing of beef and poultry, among various other industrial applications. Additionally, this segment produces tertiary amines, which are key ingredients in surfactants, biocides, and disinfectant and sanitizing agents. The Catalysts segment specializes in producing catalysts for hydroprocessing, isomerization, and alkylation reactions. It also supplies fluidized catalytic cracking catalysts and their associated additives, as well as organometallic compounds and curatives. Albemarle's chemical solutions cater to a wide array of sectors, including energy storage, petroleum refining, consumer electronics, construction, the automotive industry, lubricants, pharmaceuticals, and crop protection. The company was founded in 1887 and its headquarters are situated in Charlotte, North Carolina.
Related entities
Subsidiaries (10)
ALBEMARLE DELAWARE HOLDINGS 2 LLC
Albemarle Germany GmbH
ALBEMARLE INDIA NEW MATERIALS PRIVATE LIMITED
ALBEMARLE LITHIUM PTY LTD
Albemarle Netherlands Holdings B.V.
ALBEMARLE EUROPE
Albemarle Holdings Company Limited
Albemarle Netherlands B.V.
Albemarle New Holding GmbH
Ketjen Netherlands B.V.
Key people
Chief Financial Officer, Executive Vice President · since 2016
Raphael Crawford
President - Catalysts Global Business Unit · since 2018
Eric W. Norris
President - Lithium Global Business Unit · since 2018
Executive Vice President, Chief Administrative Officer, Corporate Secretary · since 2018
DeeAnne J. Marlow
Chief Human Resource Officer, Senior Vice President · since 2018
John Clarence Barichivich
Chief Accounting Officer, Vice President, Corporate Controller · since 2019
Meredith Bandy
Vice President - Investor Relations and Sustainability · since 2020
Lead Independent Director · since 2016
Mary Lauren Brlas
Independent Director · since 2017
Independent Director · since 2019
Gerald A. Steiner
Independent Director · since 2013
Independent Director · since 2019
Alejandro Daniel Wolff
Independent Director · since 2015
Legal address
C/O C T CORPORATION SYSTEM
4701 COX RD STE 285
GLEN ALLEN
RICHMOND, VA 23060-6808
US
4701 COX RD STE 285
GLEN ALLEN
RICHMOND, VA 23060-6808
US
Headquarters
4250 Congress St
Ste 900
Charlotte, NC 28209
US
Ste 900
Charlotte, NC 28209
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||